Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Is it the-end of improved chemotheray & less toxic methods of drug delivery?

April 26, 2017DELIVERY drug methods toxic

0

Posted

Is it the-end of improved chemotheray & less toxic methods of drug delivery?

1 Answer

0

Posted

Improved chemotherapy/targeted chemotherapy: Lived its promise on investor presentations & scientific publications. Very few of improved chemothreapy products have reached to clinic. (Liposomal Doxorubicin, Abraxane). Recenlty, Sonus pharmaceuticals announced poor safety/efficacy results of TOCOSOL (improved chemotherapy of Paclitaxel). What is the future outlook for improved chemotherapy pipeline in view of Sonus’ TOCOSOL failure & more no of “non-cytotoxic” product pipeline for cancer.